Entrada Therapeutics Inc share price logo

Entrada Therapeutics Inc

NASDAQ: TRDA

$4.40

-0.44

(-9.09%)

as on

Entrada Therapeutics Inc Stock Performance

as on October 30, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $4.35
    $5.07
    downward going graph

    1.14%

    Downside

    15.23%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.11
    $16.45
    downward going graph

    6.61%

    Downside

    273.86%

    Upside

    downward going graph

Entrada Therapeutics Inc share price movements today

Previous Close
$4.84
Open
$4.95
Volume
596.7K
Market Cap
$188.5M
Day's Low - High
$4.35 - $5.07
52 Week Low - High
$4.11 - $16.45

Entrada Therapeutics Inc Historical Returns

1 Month Return
-30.71 %
3 Month Return
-35.01 %
1 Year Return
-36.23 %
3 Year Return
-71.37 %
5 Year Return
-81.63 %

Entrada Therapeutics Inc Stock Fundamentals & Key Indicators

Check Entrada Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$188.5M

EPS (TTM)

-3.97

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.22

Industry PE ratio

-3.27

PEG Ratio

0.02

EBITDA

-164.9M

Revenue (TTM)

4.7M

Profit Margin

-754.72%

Return On Equity TTM

-57.61%

Entrada Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Entrada Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Entrada Therapeutics Inc image
Entrada Therapeutics Inc
Buy$188.5M-81.63%-1.22-754.72%0.00%
Moderna image
Moderna
Neutral$85.5B-35.47%-26.84-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$134.2B192.00%30.5886.04%0.00%
Regeneron image
Regeneron
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Entrada Therapeutics Inc Stock including INR - Dollar returns

The Entrada Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Entrada Therapeutics Inc investment value today

Current value as on today

₹68,704

Returns

-₹31,296

(-31.3%)

Returns from Entrada Therapeutics Inc Stock

-₹36,232 (-36.23%)

Dollar Impact

₹4,935 (+4.94%)

Analyst Recommendation on Entrada Therapeutics Inc Stock

Based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for Entrada Therapeutics Inc. Average target price of $19

Entrada Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Entrada Therapeutics Inc.

What analysts predicted

76.84%UPSIDE

Target Price

$19

Current Price

$4.4

Analyzed by

2 Analysts

Target

$19.00

Entrada Therapeutics Inc target price $19, a slight upside of 76.84% compared to current price of $4.4. According to 2 analysts rating.

Indian Investors' Interest in Entrada Therapeutics Inc Stock

Search interest for Entrada Therapeutics Inc Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-48% versus previous 30 day period

Entrada Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
59
94
19
37
20
1
1
1
0
0
Gross Profit
59
94
19
37
20
1
-36
0
0
0
Operating Income
21
53
-21
-5
-21
-46
-47
-42
-42
-44
EBITDA
26
58
-14
0
-16
-41
-42
-41
-38
-41
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
1
1
-2
0
0
Income Before Tax
25
57
-15
0
-17
-42
-43
-39
-39
-42
Income Tax Expense
1
2
-1
-1
-
0
0
0
0
0
Net Income
23
55
-14
1
-17
-43
-44
-39
-39
-42
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
-2276.77%
31.79%
8.00%
100.00%

Entrada Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
129
210
25
Gross Profit
0
0
-
-
129
210
21
Operating Income
-11
-26
-51
-97
-3
47
-155
EBITDA
-11
-26
-50
-90
14
70
-138
Interest Expense
-
-
-
2
-
-
-
Depreciation
0
0
1
1
2
3
4
Income Before Tax
-5
-26
-51
-94
12
66
-142
Income Tax Expense
-
-
-
-
18
0
0
Net Income
-4
-26
-51
-94
-6
65
-143
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
83.89%

Entrada Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
23
55
-14
1
-17
-43
-44
-39
-39
-42
Operating Cash Flow
-25
39
-24
-31
-38
-29
-28
-32
-41
-32
Investing Cash Flow
26
-24
-82
53
4
33
49
29
26
54
Financing Cash Flow
0
101
0
1
0
0
0
0
0
0
Change in Cash
0
116
-107
23
-33
4
20
-2
-14
22

Entrada Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-26
-51
-94
-6
65
-143
Operating Cash Flow
-10
-25
-50
-93
139
-41
-128
Investing Cash Flow
0
-2
-4
-148
-138
-27
116
Financing Cash Flow
0
50
307
0
21
102
0
Change in Cash
16
22
252
-245
22
33
-10

Global Institutional Holdings in Entrada Therapeutics Inc

Check out the Institutions with significant holdings in Entrada Therapeutics Inc.

Funds
Holdings
Felix Baker
13.03%
Vanguard
3.85%
iShares
3.57%
VANGUARD INDEX FUNDS
3.18%
Fidelity Salem Street Trust
0.94%
See all

Entrada Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 14 October

    Wed, 05:50 PM

    -

    Entrada Therapeutics reports positive topline results from Phase 1/2 ELEVATE-45-201 study of ENTR-601-45 in Duchenne muscular dystrophy patients.

Insights on Entrada Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 727.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 200.7% return, outperforming this stock by 272.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, TRDA stock has moved down by -30.7%

About Entrada Therapeutics Inc

Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate, ENTR-601-44, is currently undergoing preclinical assessment for its potential in addressing both Duchenne muscular dystrophy and myotonic dystrophy type 1. Furthermore, Entrada is actively developing EEV-PMO-CAG, also targeting myotonic dystrophy type 1. Incorporated in 2016, the firm was formerly known as CycloPorters, Inc., before officially changing its name to Entrada Therapeutics, Inc. in October 2017. The company maintains its corporate headquarters in Boston, Massachusetts.
OrganisationEntrada Therapeutics Inc
HeadquartersOne Design Center Place, Boston, MA, 02210, US
IndustryBiotechnology
CEODipal Doshi

Key Management of Entrada Therapeutics Inc

Name

Title

Mr. Nathan J. Dowden

President & COO

Dr. Natarajan Sethuraman Ph.D.

President of Research & Development

Mr. Kory James Wentworth CPA

CFO & Treasurer

Dr. Jared Cohen J.D., Ph.D.

General Counsel

Mr. Dipal Doshi

CEO & Director

FAQs

What is Entrada Therapeutics Inc share price today?

Entrada Therapeutics Inc share price today is $4.40 as on at the close of the market. Entrada Therapeutics Inc share today touched a day high of $5.07 and a low of $4.35.

What is the 52 week high and 52 week low for Entrada Therapeutics Inc share?

Entrada Therapeutics Inc share touched a 52 week high of $16.45 on and a 52 week low of $4.11 on . Entrada Therapeutics Inc stock price today i.e. is closed at $4.40,which is 73.25% down from its 52 week high and 7.08% up from its 52 week low.

What is Entrada Therapeutics Inc's market capitalisation today?

Entrada Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Entrada Therapeutics Inc Stock (TRDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Entrada Therapeutics Inc on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Entrada Therapeutics Inc Stock (TRDA) from India?

Indian investors can start investing in Entrada Therapeutics Inc (TRDA) shares with as little as ₹95.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.50 in Entrada Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Entrada Therapeutics Inc share’s latest price of $4.40 as on October 30, 2026 at 8:45 am IST, you will get 2.2727 shares of Entrada Therapeutics Inc. Learn more about fractional shares .

What are the returns that Entrada Therapeutics Inc has given to Indian investors in the last 5 years?

Entrada Therapeutics Inc stock has given -81.63% share price returns and 27.03% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?